Physician profile
Shiv Dixit
NPI 1568995603
$26,148.98
in general payments reported to CMS, 2019-2025
7 companies · $7,569 in 2025
The $7,569 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $142 · 2024: $18K · 2025: $7,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Travel and Lodging: $6,363 · Food and Beverage: $4,627 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Travel and Lodging | $6,363.06 |
| Food and Beverage | $4,626.67 |
| Education | $159.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,663.09 | 2024-2025 | Assurity, Tacticath Ablation Catheter, Sensor Enabled, Aveir |
| Boston Scientific Corporation | $3,984.02 | 2023-2025 | Versacross Access Solution, Farapulse, Accolade Sr |
| Biotronik INC. | $2,630.74 | 2025 | |
| Biosense Webster, INC. | $2,320.53 | 2024-2025 | Carto 3 |
| Medtronic, INC. | $441.80 | 2023-2025 | Affera Mapping System, Micra |
| Philips North America LLC | $55.80 | 2024 | (Bs2) Lm Undivided |
| Abiomed | $53.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiv Dixit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.